{"nct_id":"NCT02698475","title":"An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of Age","status":"COMPLETED","status_verified_date":"2021-09","start_date":"2016-05","start_date_type":"ACTUAL","primary_completion_date":"2017-12","primary_completion_date_type":"ACTUAL","completion_date":"2020-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["JNJ"]}